NCT05697211 - ORal IrON Supplementation with Ferric Maltol in Treating Iron Deficiency and Anaemia in Patients with Heart Failure (ORION-HF) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 21, 2023

Primary Completion Date

January 8, 2025

Study Completion Date

January 8, 2025

Conditions

Heart Failure, Left-sidedAnemia, Iron Deficiency

Interventions

DRUG

Ferric maltol 30 mg (Feraccru®)

In this trial Feraccru® 30 mg hard capsules will be used. Each capsule contains 30 mg iron (as ferric maltol), 91.5 mg of lactose, 0.5 mg of Allura Red AC (E129) and 0.3 mg Sunset Yellow FCF (E110) as excipients with known effects.

Trial Locations (1)

30625

Hannover Medical School, Department of Cardiology and Angiology, Hanover